Skip to Content

V2676 15 mg (Dextroamphetamine Sulfate Extended-Release 15 mg)

Pill with imprint V2676 15 mg is Brown & Clear, Capsule-shape and has been identified as Dextroamphetamine Sulfate Extended-Release 15 mg. It is supplied by Par Pharmaceutical, Inc..

Dextroamphetamine is used in the treatment of adhd; narcolepsy and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Dextroamphetamine 15 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for V2676 15 mg

Dextroamphetamine Sulfate Extended-Release

Imprint
V2676 15 mg
Strength
15 mg
Color
Brown & Clear
Size
16.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
CNS stimulants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Par Pharmaceutical, Inc.
Manufacturer
Vintage Pharmaceuticals, LLC
National Drug Code (NDC)
00603-2676
Inactive Ingredients
corn starch, dibutyl sebacate, ethylcellulose (10 mPa.s), hypromellose 2910 (50 mPa.s), magnesium stearate, polyethylene glycol 3350, sucrose, sodium lauryl sulfate, magnesium silicate, D&C Red No. 28, FD&C Blue No. 1, gelatin, titanium dioxide, ferrosoferric oxide, ferric oxide red, ferric oxide yellow, povidone, propylene glycol, sodium hydroxide, shellac, D&C Yellow No. 10

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.